Stratification of Chemotherapy-Treated Stage III Colorectal Cancer Patients Using Multiplexed Imaging and Single Cell Analysis of T Cell Populations
暂无分享,去创建一个
D. Longley | P. Laurent-Puig | A. Corwin | M. Lawler | A. Santamaría-Pang | J. Prehn | S. Van Schaeybroeck | A. Sood | J. Graf | Sanghee Cho | E. McDonough | F. Ginty | M. Salvucci | M. Loughrey | A. Lindner | X. Stachtea | Sonali Dasgupta
[1] A. Lièvre,et al. Immune scores in colorectal cancer: Where are we? , 2020, European journal of cancer.
[2] L. Terrazas,et al. Relevance of Regulatory T Cells during Colorectal Cancer Development , 2020, Cancers.
[3] Inchul Cho,et al. Tissue regulatory T cells , 2020, Immunology.
[4] S. M. Toor,et al. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients , 2019, Front. Immunol..
[5] Raphael A. Pelossof,et al. A KRAS mutation is associated with an immunosuppressive tumor microenvironment in mismatch-repair proficient colorectal cancer. , 2019, Journal of Clinical Oncology.
[6] Shimin Wang,et al. Tumor-infiltrating FoxP3+ Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis , 2017, Oncotarget.
[7] P. Trzonkowski,et al. Cell-Based Therapies with T Regulatory Cells , 2017, BioDrugs.
[8] Maohui Feng,et al. Foxp3 expression in CD4+CD25+Foxp3+ regulatory T cells promotes development of colorectal cancer by inhibiting tumor immunity , 2016, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[9] K. Sheahan,et al. Enrichment of Inflammatory IL-17 and TNF-α Secreting CD4+ T Cells within Colorectal Tumors despite the Presence of Elevated CD39+ T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1 , 2016, Front. Oncol..
[10] E. Wherry,et al. Molecular and cellular insights into T cell exhaustion , 2015, Nature Reviews Immunology.
[11] Hongtu Zheng,et al. Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival , 2014, Molecular Cancer.
[12] S. Yun,et al. Clinical impact of tumor‐infiltrating lymphocytes for survival in stage II colon cancer , 2010, Cancer.
[13] P. Laurent-Puig,et al. Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.